abstract |
The present invention relates to a compound whose structure is represented by formula (I) or its stereoisomer, tautomer or pharmaceutically acceptable salt or solvate or prodrug thereof, its preparation method, and containing these regulators The pharmaceutical composition and its use in the treatment of RORĪ³-mediated inflammatory, metabolic and autoimmune diseases. |